Home/Filings/4/0001104659-22-063970
4//SEC Filing

Laumas Sandeep 4

Accession 0001104659-22-063970

CIK 0001720893other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 6:48 PM ET

Size

5.5 KB

Accession

0001104659-22-063970

Insider Transaction Report

Form 4
Period: 2022-05-19
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-19+17,00017,000 total
    Exercise: $13.24Exp: 2032-05-19Common Stock (17,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.

Issuer

BioXcel Therapeutics, Inc.

CIK 0001720893

Entity typeother

Related Parties

1
  • filerCIK 0001721664

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 6:48 PM ET
Size
5.5 KB